1
------
FORM 3
------ U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
------------------------------------------------------------------------------------------------------------------------------------
1. Name and Address of Reporting Person(1)|2. Date of Event Requiring Statement |5. Relationship of Reporting Person
| (Month/Day/Year) | to Issuer (Check all applicable)
NEAVES, WILLIAM B. | 03/13/01 | X Director 10% Owner
-------------------------------------------------------------------------------------------| ----- -----
(Last) (First) (Middle) |3. IRS Identification |4. Issuer Name and Ticker| Officer (give title below)
| Number of | or Trading Symbol | -----
| Reporting Person, | | Other (specify below)
THE STOWERS INSTITUTE MEDICAL RESEARCH | if an Entity |CERNER CORPORATION (CERN)| -----
1000 EAST 50TH STREET | (Voluntary) | |
------------------------------------------| |-------------------------|----------------------------------------
(Street) | |6. If Amendment, Date of |7. Individual or Joint/Group Filing
| | Original | (Check applicable line)
| | (Month/Day/Year) | X Form Filed by One Reporting Person
| | | --
KANSAS CITY, MO 64110 | | 03/19/01 | Form Filed by More Than One
------------------------------------------|------------------------------------------------| -- Reporting Person
(City) (State) (Zip) | |
| |
------------------------------------------------------------------------------------------------------------------------------------
TABLE I -- NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED
------------------------------------------------------------------------------------------------------------------------------------
1. Title of Security | 2. Amount of Securities | 3. Ownership Form: | 4. Nature of Indirect Beneficial Ownership
(Instr. 4) | Beneficially Owned | Direct (D) or | (Instr. 4)
| (Instr. 4) | Indirect (I) |
| | (Instr. 5) |
----------------------------------|---------------------------|---------------------|-----------------------------------------------
| | |
----------------------------------|---------------------------|---------------------|-----------------------------------------------
| | |
----------------------------------|---------------------------|---------------------|-----------------------------------------------
| | |
----------------------------------|---------------------------|---------------------|-----------------------------------------------
| | |
----------------------------------|---------------------------|---------------------|-----------------------------------------------
| | |
----------------------------------|---------------------------|---------------------|-----------------------------------------------
| | |
----------------------------------|---------------------------|---------------------|-----------------------------------------------
| | |
----------------------------------|---------------------------|---------------------|-----------------------------------------------
| | |
----------------------------------|---------------------------|---------------------|-----------------------------------------------
| | |
----------------------------------|---------------------------|---------------------|-----------------------------------------------
| | |
----------------------------------|---------------------------|---------------------|-----------------------------------------------
| | |
------------------------------------------------------------------------------------------------------------------------------------
2
FORM 3 (CONTINUED) TABLE II -- DERIVATIVE SECURITIES BENEFICIALLY OWNED
(E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
-----------------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative | 2. Date Exercisable | 3. Title and Amount of Securities |4. Conversion |5. Ownership |6. Nature of
Security (Instr. 4) | and Expiration Date | Underlying Derivative Securities | or Exercise | Form of | Indirect
| (Month/Day/Year) | (Instr. 4) | Price of | Derivative| Beneficial
| | | Derivative | Security: | Ownership
| | | Security | Direct | (Instr. 5)
| | | | (D) or |
|------------------------|--------------------------------------| | Indirect |
| | | | Amount or | | (I) |
| Date | Expiration| | Number of | | (Instr. 5)|
| Exercisable| Date | Title | Shares | | |
-----------------------|------------|-----------|-----------------------|--------------|---------------|-------------|--------------
NON-QUALIFIED STOCK | | | | | | |
OPTION (RIGHT TO BUY) | | 03/23/11 | COMMON STOCK | 20,000 |$34.000000 | D |
-----------------------|------------|-----------|-----------------------|--------------|---------------|-------------|--------------
| | | | | | |
-----------------------|------------|-----------|-----------------------|--------------|---------------|-------------|--------------
| | | | | | |
-----------------------|------------|-----------|-----------------------|--------------|---------------|-------------|--------------
| | | | | | |
-----------------------|------------|-----------|-----------------------|--------------|---------------|-------------|--------------
| | | | | | |
-----------------------|------------|-----------|-----------------------|--------------|---------------|-------------|--------------
| | | | | | |
-----------------------|------------|-----------|-----------------------|--------------|---------------|-------------|--------------
| | | | | | |
-----------------------|------------|-----------|-----------------------|--------------|---------------|-------------|--------------
| | | | | | |
-----------------------|------------|-----------|-----------------------|--------------|---------------|-------------|--------------
| | | | | | |
-----------------------|------------|-----------|-----------------------|--------------|---------------|-------------|--------------
| | | | | | |
-----------------------|------------|-----------|-----------------------|--------------|---------------|-------------|--------------
| | | | | | |
-----------------------|------------|-----------|-----------------------|--------------|---------------|-------------|--------------
| | | | | | |
------------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses:
/s/ William B. Neaves 07/10/01
-------------------------------- -------
Signature of Reporting Person(1) Date
(1) Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure.
Page 2
(Print or Type Responses)
3
NEAVES, WILLIAM B. CERNER CORPORATION (CERN) PAGE 3 OF 3 PAGES
THE STOWERS INSTITUTE MEDICAL RESEARCH 03/13/01
1000 EAST 50TH STREET
KANSAS CITY, MO 64110
AN AMENDED FORM 3 IS BEING FILED DUE TO A CLERICAL ERROR.